首页|老年高血压患者实施小剂量阿托伐他汀钙联合苯磺酸氨氯地平治疗的临床价值分析

老年高血压患者实施小剂量阿托伐他汀钙联合苯磺酸氨氯地平治疗的临床价值分析

扫码查看
目的 观察老年高血压患者实施小剂量阿托伐他汀钙联合苯磺酸氨氯地平治疗的临床价值。方法 50 例老年高血压患者,以随机数字表法分成对照组及研究组,各 25 例。对照组以苯磺酸氨氯地平治疗,研究组以小剂量阿托伐他汀钙联合苯磺酸氨氯地平治疗。比较两组患者治疗前后的血压、血脂指标水平,治疗效果,药物不良反应发生情况。结果 治疗后,研究组患者的舒张压、收缩压、总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇水平分别为(82。62±3。46)mm Hg、(122。29±4。18)mm Hg、(3。18±0。79)mmol/L、(1。36±0。24)mmol/L、(1。18±0。12)mmol/L、(2。21±0。07)mmol/L,(1 mm Hg=0。133 kPa)较治疗前显著改善,且优于对照组的(86。77±4。29)mm Hg、(129。97±6。20)mm Hg、(6。92±0。68)mmol/L、(3。43±0。48)mmol/L、(0。86±0。09)mmol/L、(4。48±1。08)mmol/L,具有显著差异性(P<0。05);对照组患者治疗后的舒张压、收缩压低于治疗前,具有显著差异性(P<0。05),但对照组患者治疗后的总胆固醇、甘油三酯、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇水平与治疗前比较,无显著差异性(P>0。05)。研究组患者治疗总有效率 96。00%高于对照组的 68。00%,具有显著差异性(P<0。05)。两组药物不良反应发生率比较,无显著差异性(P>0。05)。结论 老年高血压患者实施苯磺酸氨氯地平片治疗可控制患者血压水平,而联合使用小剂量阿托伐他汀钙治疗后可在控制血压水平的情况下改善血脂指标,提升治疗效果,且不增加药物不良反应,联合用药安全性较高,值得临床推广。
Clinical value analysis of low-dose atorvastatin calcium combined with amlodipine besylate in elderly hypertensive patients
Objective To observe the clinical value of low-dose atorvastatin calcium combined with amlodipine besylate in elderly hypertensive patients.Methods 50 elderly patients diagnosed with hypertension were randomly divided into a control group and a study group according to random numerical table,each consisting of 25 patients.The control group was treated with amlodipine besylate,and the study group was treated with low-dose atorvastatin calcium combined with amlodipine besylate.The blood pressure levels and blood lipid indicators before and after treatment,treatment effect,andadverse drug reactions were compared between the two groups.Results After treatment,the diastolic blood pressure,systolic blood pressure,total cholesterol,triglyceride,high density lipoprotein cholesterol,and low density lipoprotein cholesterol were(82.62±3.46)mm Hg(1 mm Hg=0.133 kPa),(122.29±4.18)mm Hg,(3.18±0.79)mmol/L,(1.36±0.24)mmol/L,(1.18±0.12)mmol/L,and(2.21±0.07)mmol/L in the study group,which were significantly improved compared with those before treatment in this group,and were better than(86.77±4.29)mm Hg,(129.97±6.20)mm Hg,(6.92±0.68)mmol/L,(3.43±0.48)mmol/L,(0.86±0.09)mmol/L,and(4.48±1.08)mmol/L in the control group.There were significant differences(P<0.05).After treatment,the diastolic blood pressure and systolic blood pressure of the control group were lower than those before treatment,and there was significant differences(P<0.05),but the levels of total cholesterol,triglycerides,high density lipoprotein cholesterol,and low density lipoprotein cholesterol did not show any significant differences compared with those before treatment(P>0.05).The total effective rate of 96.00%in the study group was higher than 68.00%in the control group,and there was significant difference(P<0.05).There was no significant difference in the incidence of adverse drug reactions between the two groups(P>0.05).Conclusion For elderly hypertensive patients,the implementation of amlodipine besylate tablets can control the patient's blood pressure level.However,combined use of low-dose atorvastatin calcium tablets can improve blood lipid indicators and improve treatment effectiveness while maintaining stable blood pressure levels,without increasing adverse drug reactions.The combination therapy is safe and worthy of clinical promotion.

Elderly hypertensionLow-dose atorvastatin calciumAmlodipine besylateCombination therapyClinical value

谢家勇

展开 >

362100 晋江市新塘街道社区卫生服务中心

老年高血压 小剂量阿托伐他汀钙 苯磺酸氨氯地平 联合治疗 临床价值

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(22)